BY: RAJEEV SRINIVASAN PUBLISHED ON NOVEMBER 15, 2020 The announcement by US giant Pfizer and startup BioNTech about their candidate vaccine for Covid-19 has been greeted with understandable euphoria, as people are chafing under the ‘new normal’ of lockdowns and restrictions. Indeed, markets cheered: stock market indices hit new highs; airline stocks soared; Zoom’s (an […]Read More